Skip to main content
Clinical Trials/TCTR20180804001
TCTR20180804001
Completed
Phase 1

Is Parent-Child interaction therapy effective on aggression and biological indices in pre-school children with parents who use Tetrahydrocannabinol? A double-blind randomized controlled trial in an Iranian sample

none0 sites64 target enrollmentAugust 4, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
All stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration.
Sponsor
none
Enrollment
64
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 4, 2018
End Date
October 1, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria were: 1\) age range of 5\-7 years in children; 2\) the diagnosis of dependence to Gul with a given dose for at least one of the parents; 3\) the diagnosis of aggression syndrome in two clinical domains and evaluation of questionnaires; 4\) age range of 20 \-45 years for parents; and 5\) the ability to read and write.

Exclusion Criteria

  • The exclusion criteria for mothers and children were as follow: 1\) lack of natural intelligence with a criterion of less than 70; 2\) use of more than three months from psychiatric medications due to the possible effect on the psychological syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials